Posted in | News | Chemistry | Design and Innovation

Breakthrough Catalyst Allows Production of a Wider Range of Polyalkylene Carbonates

Empower Materials of New Castle Delaware has developed a new breakthrough catalyst to synthesize Polyalkylene carbonates, known as QPAC. The new catalyst system allows for a wider range of molecular weights and improved control of the byproduct content. This catalyst also is more effective than the existing system, therefore making the process more efficient and higher performing.

This new catalyst system will allow Empower Materials to serve our customers better by improving the overall product quality and offering a more extensive list of QPAC products. We are very excited to have recently introduced this new process into production.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Empower Materials. (2021, January 07). Breakthrough Catalyst Allows Production of a Wider Range of Polyalkylene Carbonates. AZoM. Retrieved on April 19, 2024 from https://www.azom.com/news.aspx?newsID=20319.

  • MLA

    Empower Materials. "Breakthrough Catalyst Allows Production of a Wider Range of Polyalkylene Carbonates". AZoM. 19 April 2024. <https://www.azom.com/news.aspx?newsID=20319>.

  • Chicago

    Empower Materials. "Breakthrough Catalyst Allows Production of a Wider Range of Polyalkylene Carbonates". AZoM. https://www.azom.com/news.aspx?newsID=20319. (accessed April 19, 2024).

  • Harvard

    Empower Materials. 2021. Breakthrough Catalyst Allows Production of a Wider Range of Polyalkylene Carbonates. AZoM, viewed 19 April 2024, https://www.azom.com/news.aspx?newsID=20319.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Trending Stories

More Content from Empower Materials

See all content from Empower Materials

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback